Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1986-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.83.5.1499PMID 3485288PMCID PMC323104
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Purification of Epstein-Barr virus DNA polymerase from P3HR-1 cells

  1985cited by this paper
• A second nuclear protein is encoded by Epstein-Barr virus in latent infection.

  1985cited by this paper
• Characterization of a second Epstein‐Barr virus‐determined nuclear antigen associated with the BamHI WYH region of EBV DNA

  1985cited by this paper
• Antibodies against synthetic peptides react with the second Epstein‐Barr virus‐associated nuclear antigen.

  1985cited by this paper
• Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells

  1985cited by this paper
• The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non‐transforming strain (P3HR‐1) of the virus.

  1984cited by this paper
• Identification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis

  1984cited by this paper
• A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.

  1984cited by this paper
• Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen.

  1984cited by this paper
• Epstein-Barr virus susceptibility of normal human B lymphocyte populations

  1984cited by this paper
• One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain.

  1983cited by this paper
• Simple repeat array in Epstein-Barr virus DNA encodes part of the Epstein-Barr nuclear antigen.

  1983cited by this paper
• An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo.

  1983cited by this paper
• Stable expression in mouse cells of nuclear neoantigen after transfer of a 3.4-megadalton cloned fragment of Epstein-Barr virus DNA.

  1982cited by this paper
• Identification of an Epstein-Barr virus nuclear antigen by fluoroimmunoelectrophoresis and radioimmunoelectrophoresis

  1981cited by this paper
• Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines

  1973cited by this paper

• Regulatory role of CDX 2 and NOX 4 expression associated with recurrent nasopharyngeal carcinoma

  2018cites this paper
• Studies on the expression and function of Epstein-Barr virus encoded microRNAs in Burkitt lymphoma

  2013cites this paper
• Viral Expression Vectors

  2011cites this paper
• Epstein-Barr virus genome loss from Endemic Burkitt lymphoma and its effect on cell phenotype

  2009cites this paper
• Modern diagnosis of Epstein-Barr virus infections and post-transplant lymphoproliferative disease

  2007cites this paper
• Epstein-Barr Virus EBNA-3C Is Targeted to and Regulates Expression from the Bidirectional LMP-1/2B Promoter

  2006cites this paper
• Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis

  2004cites this paper
• Expression of the anti-apoptotic bfl-1/A1 gene is regulated by the Epstein Barr virus nuclear antigen 2(EBNA2)

  2003cites this paper
• Novel approaches to therapeutic cancer vaccines

  2003cites this paper
• Transcriptional Regulatory Properties of Epstein-Barr Virus Nuclear Antigen 3C Are Conserved in Simian Lymphocryptoviruses

  2003cites this paper
• Antibodies for detecting EBV latent proteins.

  2001cites this paper
• Regulation of apoptosis by the Epstein-Barr virus latent membrane protein LMP1

  2001cites this paper
• Epstein-Barr Virus Nuclear Antigen-1-Dependent and -Independent oriP-Binding Cellular Proteins

  2001cites this paper
• Molecular virology of Epstein-Barr virus.

  2001cites this paper
• Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma.

  2000cites this paper
• Epstein-Barr virus immortalization and latency.

  1999cites this paper
• Multiple Functions within the Epstein-Barr Virus EBNA-3A Protein

  1998influential citation
• Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa.

  1998influential citation
• Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21

  1997influential citation
• Epstein—Barr Virus and Malignant Lymphomas

  1997cites this paper
• Detection of EBER nuclear RNA in T‐cell lymphomas involving the skin‐an in situ hybridization study

  1996cites this paper
• Induction of pleckstrin by the Epstein-Barr virus nuclear antigen 3 family.

  1996cites this paper
• Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA

  1996cites this paper
• Expression of Epstein‐Barr virus‐encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma

  1996cites this paper
• Epstein-Barr nuclear antigen-3 and -4 interact with RBP-2N, a major isoform of RBP-J kappa in B lymphocytes.

  1996cites this paper
• Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.

  1996cites this paper
• Molecular epidemiology of Epstein-Barr virus infection.

  1995cites this paper
• Biologic treatment of human cancer.

  1995cites this paper
• Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas.

  1995cites this paper
• Response to cAMP levels of the Epstein‐Barr virus EBNA2‐inducible LMP1 oncogene and EBNA2 inhibition of a PP1‐like activity.

  1994cites this paper
• Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.

  1994cites this paper
• The B cell-immortalizing functions of Epstein-Barr virus.

  1994cites this paper
• Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.

  1993cites this paper
• Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequences.

  1993cites this paper
• Epstein-Barr virus and CD30+ malignant lymphomas.

  1993cites this paper
• The EBNA2-Related Resistance Towards Alpha Interferon (IFN-α) in Burkitt's Lymphoma Cells Effects Induction of IFN-Induced Genes but Not the Activation of Transcription Factor ISGF-3

  1993cites this paper
• Epstein-Barr virus based expression vectors.

  1992cites this paper
• The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3

  1992cites this paper
• Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein‐Barr virus

  1992cites this paper
• Infektionen durch Epstein-Barr- und Zytomegalievirus

  1992cites this paper
• Decreased expression of E‐cadherin and increased invasive capacity in EBV‐LMP‐transfected human epithelial and murine adenocarcinoma cells

  1992cites this paper
• Possibilities for active immunotherapy of human cancer.

  1992cites this paper
• Biochemical characterization of Epstein-Barr virus nuclear antigen 2A and an associated ATPase activity.

  1992cites this paper
• Complementation of adenovirus early region 1a and 2a mutants by Epstein-Barr virus immortalized lymphoblastoid cell lines.

  1991cites this paper
• Expression of epstein‐barr virus‐encoded growth‐transformation‐associated proteins in lymphoproliferations of bone‐marrow transplant recipients

  1991cites this paper
• Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region

  1991cites this paper
• Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA.

  1991cites this paper
• Molecular basis for Epstein-Barr virus induced pathogenesis and disease

  1991cites this paper
• The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure.

  1991cites this paper
• Characterization of Epstein-Barr virus (EBV)-specific monoclonal antibodies /

  1990cites this paper
• Expression of the epstein‐barr virus genome in a nasopharyngeal carcinoma epithelial tumor cell line

  1990cites this paper
• Epstein-Barr virus gene expression in interferon-treated cells. Implications for the regulation of protein synthesis and the antiviral state.

  1990cites this paper
• In vitro transcriptional activation, dimerization, and DNA-binding specificity of the Epstein-Barr virus Zta protein

  1990cites this paper
• Possible role of Epstein-Barr virus infection in cutaneous T-cell lymphomas.

  1990cites this paper
• Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis.

  1990cites this paper
• Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP

  1990cites this paper
• Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins.

  1990cites this paper
• Expression of epstein‐barr virus‐encoded proteins and B‐cell markers in fatal infectious mononucleosis

  1990cites this paper
• Molecular Weight Variation of EBNAs as a Means to Identify Different Epstein-Barr Virus Isolates (EBNotyping)

  1989cites this paper
• Immunological responses to Epstein-Barr virus infection and the pathogenesis of EBV-induced diseases.

  1989cites this paper
• Expression of EBNA-3 family in fresh B lymphocytes infected with Epstein-Barr virus.

  1989cites this paper
• Responsiveness of the Epstein-Barr virus NotI repeat promoter to the Z transactivator is mediated in a cell-type-specific manner by two independent signal regions

  1989cites this paper
• Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus.

  1989cites this paper
• Epstein-Barr virus small RNA (EBER) genes: unique transcription units that combine RNA polymerase II and III promoter elements.

  1989cites this paper
• Human herpesviruses: a consideration of the latent state

  1989cites this paper
• The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.

  1989cites this paper
• The Immune Response to Glycine-Rich Sequences of Epstein-Barr Nuclear Antigen-1 (EBNA-1) in Autoimmunity: B and T Cell Epitopes

  1989cites this paper
• 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael

  1989cites this paper
• A method to identify distinctive charge configurations in protein sequences, with application to human herpesvirus polypeptides.

  1989cites this paper
• Viral latency and transformation: the strategy of Epstein-Barr virus.

  1989cites this paper
• Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication

  1989cites this paper
• Epstein-Barr virus latent gene expression during the initiation of B cell immortalization.

  1989cites this paper
• Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids

  1989cites this paper
• Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition in infectious mononucleosis. II. Kinetics of sensitization against five EBV-encoded nuclear proteins and the latent membrane protein.

  1989cites this paper
• Persistence and transfer of Epstein-Barr virus after allogeneic bone marrow transplantation.

  1989cites this paper
• B cell activation and the establishment of Epstein-Barr virus latency

  1988cites this paper
• A sixth Epstein-Barr virus nuclear protein (EBNA3B) is expressed in latently infected growth-transformed lymphocytes

  1988cites this paper
• Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus.

  1988cites this paper
• Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains

  1988cites this paper
• Expression of Epstein‐Barr virus‐encoded proteins in nasopharyngeal carcinoma

  1988cites this paper
• The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells.

  1988cites this paper
• Epstein-Barr virus gene expression in nasopharyngeal carcinoma.

  1988cites this paper
• Unchanged expression of Epstein-Barr virus-determined nuclear antigen-1 in productive virus cycle.

  1988cites this paper
• A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes

  1988cites this paper
• Three epstein‐barr virus (EBV)‐determined nuclear antigens induced by the BamHI E region of EBV DNA

  1988cites this paper
• Induction of Epstein-Barr virus antigens by hydroxyurea.

  1988cites this paper
• Prediction and demonstration of a novel Epstein-Barr virus nuclear antigen.

  1988cites this paper
• Characterization of a latent protein encoded by the large internal repeats and the BamHI Y fragment of the Epstein-Barr virus (EBV) genome.

  1988cites this paper
• Mutational analysis of Epstein-Barr virus nuclear antigen 1 (EBNA 1).

  1988cites this paper
• Isolation and characterization of the genes for two small RNAs of herpesvirus papio and their comparison with Epstein-Barr virus-encoded EBER RNAs

  1988cites this paper
• BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins.

  1988cites this paper
• Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency.

  1988cites this paper
• The Epstein-Barr virus proteins.

  1988cites this paper
• Basic virological aspects of Epstein-Barr virus infection.

  1988cites this paper
• Purification and characterization of the epstein‐barr virus nuclear antigen 2 using monoclonal antipeptide antibodies

  1988cites this paper
• Maintenance of growth transformation with Epstein-Barr virus is mediated by secretion of autocrine growth factors in two serum-free B-cell lines

  1988cites this paper
• Expression of the Epstein‐Barr virus encoded EBNA‐I gene in stably transfected human and murine cell lines

  1988cites this paper
• On the Miology of Rheumatoid Arthritis

  1988cites this paper
• Epstein-Barr virus nuclear antigen type 1 binding: electron microscopy.

  1988cites this paper
• Detection of antibodies to the Epstein-Barr virus nuclear antigens in the sera from patients with systemic lupus erythematosus.

  1988cites this paper